Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Outro, a de-prescribing startup, raises $7M in pre-seed and seed funding to help patients safely discontinue antidepressants.
Amount Raised
$7 Million
Round Type
Seed
Description
Outro, a de-prescribing startup, announced today that it has raised $7 million in pre-seed and seed funding. The company focuses on helping patients safely discontinue antidepressants by addressing withdrawal symptoms and providing structured tapering support. Outro employs healthcare professionals, including nurse practitioners like Kristen Massingill, who work with patients on medication reduction strategies. The funding will support the company's mission to improve the de-prescribing process and patient outcomes.
Fundz sees it the moment Outro raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Outro raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.